Patent Assignment
Reel/Frame 030049/0894
Assignment of Assignor's Interest
Recorded: 2013-03-20
Pages: 8
Assignor
NEUROSEARCH A/S
Executed: 2013-03-18
Assignee
ANIONA APS
C/O DREJER, SKOVBAKKEN 32, FARUM, 3620, DENMARK
Covered Properties
(94)
Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Purinyl Derivatives and Their Use as Potassium Channel Modulators
Pyrazine Derivatives and Their Use as Potassium Channel Modulators
Carbonylamino Derivatives Useful for the Treatment of Certain Inflammatory Disorders
Benzimidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
Application:
13/129,186 →
Publication:
US 2011/0257210
Benzimidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
Pyrazolyl-Pyrimidine Derivatives and Their Use as Potassium Channel Modulators
8-Azabicyclo[3.2.1]Oct-2-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel Indolyl-Oxadiazolyl-Diazabicyclononane Derivatives and Their Medical and Diagnostical Use
Substituted [1,2,4]Triazolo[1,5-a]Pyrimidines and Their Use as Potassium Channel Modulators
Substituted [1,2,4]Triazolo[1,5-a]Pyrimidines and Their Use as Potassium Channel Modulators
Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Application:
13/575,712 →
Publication:
US 2013/0040985
Indole-2,3-Dione-3-Oxime Derivatives, Their Preparation and Use
Patent:
5,917,053 →
Application:
08/809,082 →
Phenyl Derivatives Containing an Acidic Group, Their Preparation and Their Use as Chloride Channel Blockers
Patent:
6,417,393 →
Application:
09/194,083 →
Substituted Phenyl Derivatives, Their Preparation and Use
8-Azabicyclo (3,2,1) Oct-2-Ene and Octane Derivatives as Cholinergic Ligands at Nicotinic Ach Receptors
Patent:
6,645,977 →
Application:
09/450,637 →
8-Azabicyclo(3,2,1)Oct-2 Ene and Octane Derivatives as Cholinergic Ligands at Nicotinic Ach Receptors
Azacyclooctane and Heptane Derivatives, Their Preparation and Use in Therapy
Patent:
6,420,395 →
Application:
09/450,636 →
Azacyclooctane and Heptane Derivatives, Their Preparation and Use in Therapy
Azaring-Ether Derivatives and Their Use as Nicotinic Ach Receptor Modulators
Patent:
6,756,386 →
Application:
09/550,379 →
Pyridylether Derivatives, Their Preparation and Use
Chemical Compounds Having Ion Channel Blocking Activity for the Treatment of Immune Dysfunction
Novel Compounds and Their Use as Positive Ampa Receptor Modulators
Diaminocyclobutene-3,4-Dione Derivatives, Their Preparation and Use
Substituted Phenyl Derivatives, Their Preparation and Use
8-Azabicyclo[3.2.1]Oct-2-Ene and -Octane Derivatives
Novel Azabicyclo Derivatives and Their Use
Heteroaryl Diazabicycloalkanes, Their Preparation and Use
Novel Benzimidazole Derivatives and Pharmaceutical Compositions Comprising These Compounds
Isatine Derivatives with Neurotrophic Activity
3-Substituted Quinuclidines and Their Use as Nicotinic Agonists
Treatment of Affective Disorders by the Combined Action of a Nicotinic Receptor Agonist and a Monoaminergic Substance
Novel Benzimidazol-2-One Derivatives and Their Use
Cation Conducting Gabaa Receptors and Their Use
Novel Compounds, Their Preparation and Use
Potassium Channel Modulators
Novel Benzothiazine Derivatives, Their Preparation and Use
Novel Azacyclic Ethynyl Derivatives
Novel Azacyclic Ethynyl Derivatives
Novel Diazabicyclic Biaryl Derivatives
3-Substituted Quinuclidines and Their Use
Diazabicyclonane and-Decane Derivatives and Their Use as Opioid Receptor Ligands
Novel Diazabicyclic Biaryl Derivatives
Novel 8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
8-Aza-Bicyclo (3.2.1) Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Benzimidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
Diazabicyclic Aryl Derivatives as Cholinergic Receptor Modulators
Diazabicyclic Aryl Derivatives as Cholinergic Receptor Modulators
Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel Substituted Aryloxy Alkylamines and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel Azabicyclic Aryl Derivatives and Their Medical Use
Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Enantiomers of 3-Heteroaryl-8H-8-Azabicyclo (3.2.1) Oct-2-Ene and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
3,8-Substituted 8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Benzimidazole Derivatives and Their Use for Modulating the Gaba Alpha Receptor Complex
Benzimidazole Derivatives and Their Use for Modulating the Gabaalpha Receptor Complex
Novel Diazabicyclic Aryl Derivatives and Their Medical Use
Alkyl Substituted Homopiperazine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Potassium Channel Modulating Agents and Their Medical Use
Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel 3-Aza-Spiro[5,5]Undec-8-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel 3-Aza-Spiro[5.5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Imidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
Imidazole Derivatives and Their Use for Modulating the Gaba Alpha Receptor Complex
Imidazole Derivatives for the Treatment of Anxiety and Related Diseases
Novel Diazabicycylic Aryl Derivatives and Their Medical Use
Diphenylurea Derivatives and Their Use as Chloride Channel Blockers or Bkca Channel Modulators
8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Benzimidazole Derivatives and Their Use for Modulating the Gaba-Alpha Receptor Complex
Benzimidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
Benzimidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex
3,9-Diazabicyclo[3.3.1]Nonane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel 3,9-Diazabicyclo[3.3.1]Nonane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Indazolyl Derivatives Useful as Potassium Channel Modulating Agents
3, 9-Diazabicyclo(3.3.1)Non-3-Yl-Aryl Methanone Derivatives as Nicotinic Acetylcholine Receptor Agonists
Novel Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Novel 8,10-Diaza-Bicyclo[4.3.1]Decane Derivatives and Their Medical Use
Novel Chromen-2-One Derivatives
Novel Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
Purinyl Derivatives and Their Use as Potassium Channel Modulators
1,4-Diaza-Bicyclo[3.2.2]Nonyl Oxadiazolyl Derivatives and Their Medical Use
1,4-Diaza-Bicyclo[3.2.2]Nonyl Oxadiazolyl Derivatives and Their Medical Use
Novel 1,4-Diaza-Bicyclo[3.2.2]Nonyl Pyrimidinyl Derivative and Its Medical Use
Novel 1,4-Diaza-Bicyclo[3.2.2]Nonyl Pyrimidinyl Derivative and Its Medical Use
Novel 2, 3-Diamino-Quinazolinone Derivatives and Their Medical Use
NOVEL1,4-Diaza-Bicyclo[3.2.2]Nonyl Heteroaryl Derivatives Useful as Nicotinic Acetylcholine Receptor Ligands
Novel Carboxylic Acid 4-Phenylazo-Phenyl Ester Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
N-Acylhydrazone Derivatives Useful as Modulators of Nicotinic Acetylcholine Receptors
1,4-Diaza-Bicyclo[3.2.2]Nonyl Pyrimidine Derivatives and Their Medical Use
Novel 1,4-Diaza-Bicyclo[3.2.2]Nonyl Oxadiazolyl Derivatives Useful as Modulator of Nicotinic Acetylcholine Receptors
Substituted Purinyl-Pyrazole Derivatives and Their Use as Potassium Channel Modulators
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 20, 1997
From: MOLDT, PETER; WATJEN, FRANK
To: NEUROSEARCH A/S
Reel/Frame 008580/0705 →
Assignment of Assignor's Interest
Jan 22, 1999
From: CHRISTOPHERSEN, PALLE; PEDERSEN, OVE
To: NEUROSEARCH A/S
Reel/Frame 009712/0097 →
Assignment of Assignor's Interest
Nov 29, 1999
From: PETERS, DAN; OLSEN, GUNNAR M.; NIELSEN, SIMON FELDBAEK; NIELSEN, ELSBET OSTERGAARD
To: NEUROSEARCH A/S
Reel/Frame 010427/0994 →
Assignment of Assignor's Interest
Nov 29, 1999
From: PETERS, DAN; OLSEN, GUNNAR M.; NIELSEN, SIMON F.; NIELSEN, ELSEBET O.
To: NEUROSEARCH A/S
Reel/Frame 010427/0983 →
Assignment of Assignor's Interest
Oct 24, 2001
From: DAHL, BJARNE H.; CHRISTOPHERSEN, PALLE
To: NEUROSEARCH A/S
Reel/Frame 012278/0714 →
Assignment of Assignor's Interest
Mar 28, 2010
From: MADSEN, LARS SIIM; CHRISTOPHERSEN, PALLE
To: NEUROSEARCH A/S
Reel/Frame 024149/0001 →
Assignment of Assignor's Interest
Jun 2, 2010
From: ERIKSEN, BIRGITTE L.; SORENSEN, ULRIK SVANE; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 024475/0329 →
Corrective Assignment to Correct the Docket Number. Previously Recorded on Reel 024475 Frame 0329. Assignor(S) Hereby Confirms the Correct Docket Number Is 2815-0424PUS2.
Sep 16, 2010
From: ERIKSEN, BIRGITTE L.; SORENSEN, ULRIK SVANE; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 024997/0092 →
Assignment of Assignor's Interest
Jun 2, 2011
From: ERIKSEN, BIRGITTE L.; HOUGAARD, CHARLOTTE; PETERS, DAN; CHRISTOPHERSEN, PALLE
To: NEUROSEARCH A/S
Reel/Frame 026380/0957 →
Assignment of Assignor's Interest
Jul 7, 2011
From: LARSEN, JANUS S.; AHRING, PHILIP K.; NIELSEN, ELSEBET OSTERGAARD; MIRZA, NAHEED
To: NEUROSEARCH A/S
Reel/Frame 026556/0786 →
Assignment of Assignor's Interest
Jul 11, 2011
From: LARSEN, JANUS S.; AHRING, PHILIP K.; NIELSEN, ELSEBET OSTERGAARD; MIRZA, NAHEED
To: NEUROSEARCH A/S
Reel/Frame 026572/0569 →
Assignment of Assignor's Interest
Jul 14, 2011
From: PETERS, DAN; JONES, DAVID SPENCER; NIELSEN, ELSEBET OSTERGAARD
To: NEUROSEARCH A/S
Reel/Frame 026588/0877 →
Assignment of Assignor's Interest
Sep 20, 2011
From: PETERS, DAN; TIMMERMANN, DANIEL B.; DYHRING, TINO; CHRISTENSEN, JEPPE KEJSER
To: NEUROSEARCH A/S
Reel/Frame 026937/0471 →
Assignment of Assignor's Interest
Nov 23, 2011
From: SORENSEN, ULRIK SVANE; ERIKSEN, BIRGITTE L.; HOUGAARD, CHARLOTTE; STROBAEK, DORTE
To: NEUROSEARCH A/S
Reel/Frame 027276/0183 →
Assignment of Assignor's Interest
Dec 12, 2011
From: SORENSEN, ULRIK SVANE; ERIKSEN, BIRGITTE L.; HOUGAARD, CHARLOTTE; STROBAEK, DORTE
To: NEUROSEARCH A/S
Reel/Frame 027363/0508 →
Assignment of Assignor's Interest
Dec 21, 2011
From: PETERS, DAN; NIELSEN, ELSEBET OSTERGAARD; NIELSEN, KARIN SANDAGER; MUNRO, GORDON
To: NEUROSEARCH A/S
Reel/Frame 027426/0460 →
Assignment of Assignor's Interest
Oct 12, 2012
From: PETERS, DAN; MUNRO, GORDON; NIELSEN, ELSEBET OSTERGAARD; NIELSEN, KARIN SANDAGER
To: NEUROSEARCH A/S
Reel/Frame 029122/0058 →
Assignment of Assignor's Interest
Mar 4, 2013
From: ERIKSEN, BIRGITTE L; SORENSEN, ULRIK; HOUGAARD, CHARLOTTE; PETERS, DAN
To: NEUROSEARCH A/S
Reel/Frame 029917/0830 →
Assignment of Assignor's Interest
Apr 23, 2013
From: ANIONA APS
To: DANPET AB
Reel/Frame 030266/0240 →
Assignment of Assignor's Interest
Aug 6, 2013
From: ANIONA APS
To: ATAXION, INC.
Reel/Frame 030946/0329 →
Assignment of Assignor's Interest
Mar 27, 2017
From: SANIONA A/S
To: INITIATOR PHARMA A/S
Reel/Frame 041749/0065 →
Change of Name
Mar 27, 2017
From: ANIONA APS
To: SANIONA A/S
Reel/Frame 042098/0064 →
Change of Name
Apr 30, 2020
From: ANIONA APS
To: SANIONA A/S
Reel/Frame 052534/0104 →
Assignment of Assignor's Interest
May 20, 2020
From: SANIONA A/S
To: INITIATOR PHARMA A/S
Reel/Frame 052709/0527 →
Change of Address of Assignee
Oct 21, 2020
From: SANIONA A/S
To: SANIONA A/S
Reel/Frame 054396/0996 →